调查药剂师参与对急诊室结果的影响:回顾性队列研究
Carolina Ghio1, Raman Brar2, Erik Youngson3
1, BHSc, PharmD, ACPR, is with Pharmacy Services, Alberta Health Services, Calgary, Alberta.
The Canadian journal of hospital pharmacy
|January 14, 2026
概括
急诊室 (ED) 的药剂师没有改善患者流动,显示了更长的停留时间和更多的回访. 需要进一步的研究来优化ED药剂师服务,以获得更好的患者结果.
科学领域:
- 紧急医疗 紧急医疗
- 临床药房 临床药房
- 医疗保健服务研究 医疗服务研究
背景情况:
- 药剂师融入急诊室 (ED) 团队是不一致的,尽管有证据表明加强了患者护理.
- 之前的研究强调ED药剂师对护理质量措施的积极影响.
研究的目的:
- 评估ED药剂师参与对患者流动的影响,特别是ED停留时间 (LOS) 和返回ED访问.
- 描述ED药剂师管理的患者群体.
主要方法:
- 在阿尔伯塔省11家医院对成年人ED访问的回顾性队列研究.
- 分析了183,182次ED访问,将药剂师看到的患者 (7,441) 与匹配的队列进行了比较.
- 主要结局包括ED LOS和复杂的返回ED访问和7天和30天内死亡.
主要成果:
- 药剂师看的患者年龄较大,药物使用量较高,并患有更多的并发病.
- 药剂师参与与更长的ED LOS中位数 (7.7 vs. 6.7小时) 和7天 (22.1% vs. 9.2%) 和30天 (30.0% vs. 17.3%) 返回ED访问/死亡的复合率增加有关.
结论:
- 研究结果表明,目前的ED药剂师活动可能无法优化患者流动,正如增加的LOS和回访所表明的那样.
- 优化ED药剂师服务需要有针对性的策略来减少LOS和再接收.
- 高质量的研究对于完善ED药剂师实践和加强临床服务至关重要.
相关概念视频
Pharmacovigilance
1.6K
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
1.6K
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
404
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
404
Model-Independent Approaches for Pharmacokinetic Data: Noncompartmental Analysis
317
Noncompartmental analyses offer an alternative method for describing drug pharmacokinetics without relying on a specific compartmental model. In this approach, the drug's pharmacokinetics are assumed to be linear, with the terminal phase log-linear. This assumption allows for simplified analysis and interpretation of the drug's behavior in the body.
One important characteristic of noncompartmental analyses is that drug exposure increases proportionally with increasing doses. This...
One important characteristic of noncompartmental analyses is that drug exposure increases proportionally with increasing doses. This...
317
Chronopharmacokinetics: Circadian Rhythms and Influence on Drug Response
350
Circadian rhythms are cyclic changes that are crucial in plasma drug concentrations. Various standard circadian parameters, including core body temperature, heart rate, and other cardiovascular factors, directly impact disease states and the therapeutic response to drug therapy.
The time of drug administration is an important factor to consider, as it can influence the toxic dose of a drug. For example, a study conducted by Prins et al. in 1997 examined the effects of the timing of...
The time of drug administration is an important factor to consider, as it can influence the toxic dose of a drug. For example, a study conducted by Prins et al. in 1997 examined the effects of the timing of...
350
Pharmacodynamics in Geriatric Patients: Effects of Age
185
Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
185
Analysis of Population Pharmacokinetic Data
673
Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
673

